Abstract
We aimed to establish and validate an artificial intelligence-based radiomics strategy for predicting personalized responses of hepatocellular carcinoma (HCC) to first transarterial chemoembolization (TACE) session by quantitatively analyzing contrast-enhanced ultrasound (CEUS) cines. One hundred and thirty HCC patients (89 for training, 41 for validation), who received ultrasound examination (CEUS and B-mode) within 1 week before the first TACE session, were retrospectively enrolled. Ultrasonographic data was used for building and validating deep learning radiomics-based CEUS model (R-DLCEUS), machine learning radiomics-based time-intensity curve of CEUS model (R-TIC), and machine learning radiomics-based B-Mode images model (R-BMode), respectively, to predict responses (objective-response and non-response) to TACE with reference to modified response evaluation criteria in solid tumor. The performance of models was compared by areas under the receiver operating characteristic curve (AUC) and the DeLong test was used to compare different AUCs. The prediction robustness was assessed for each model. AUCs of R-DLCEUS, R-TIC, and R-BMode were 0.93 (95% CI, 0.80-0.98), 0.80 (95% CI, 0.64-0.90), and 0.81 (95% CI, 0.67-0.95) in the validation cohort, respectively. AUC of R-DLCEUS shows significant difference compared with that of R-TIC (p = 0.034) and R-BMode (p = 0.039), whereas R-TIC was not significantly different from R-BMode. The performance was highly reproducible with different training and validation cohorts. DL-based radiomics method can effectively utilize CEUS cines to achieve accurate and personalized prediction. It is easy to operate and holds good potential for benefiting TACE candidates in clinical practice. • Deep learning (DL) radiomics-based CEUS model can accurately predict responses of HCC patients to their first TACE session by quantitatively analyzing their pre-operative CEUS cines. • The visualization of the 3D CNN analysis adopted in CEUS model provided direct insight into what computers "see" on CEUS cines, which can help people understand the interpretation of CEUS data. • The proposed prediction method is easy to operate and labor-saving for clinical practice, facilitating the clinical treatment decision of HCCs with very few time costs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.